SABS stock results show that SAB Biotherapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
Articles
Why Is American Vanguard (AVD) Stock Down 28% Today?
American Vanguard stock is down on Friday after AVD investors learned of the company missing Q2 estimates and cutting revenue guidance. More
Why Is AN2 Therapeutics (ANTX) Stock Down 35% Today?
AN2 Therapeutics stock is down on Friday after ANTX investors learned of the company terminating its EBO-301 Phase 2/3 clinical trial. More
The 3 Best Cloud Gaming Stocks to Buy in August 2024
These fallen tech companies may be the best cloud gaming stocks to buy as they do their best to advance the tech. More
Why Is Nauticus Robotics (KITT) Stock Up 40% Today?
Nauticus Robotics stock is up on Friday as KITT investors learn of a new testing agreement that will save the company money. More
CYAN Stock Earnings: Cyanotech Reported Results for Q1 2025
Cyanotech just reported results for the first quarter of 2025. More
ECO Stock Earnings: Okeanis Eco Tankers Reported Results for Q2 2024
Okeanis Eco Tankers just reported results for the second quarter of 2024. More
